{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:40:58Z","timestamp":1782286858196,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This multicentric study evaluated short- and mid-term clinical outcomes, with specific focus on the need for repeat revascularization, in patients undergoing coronary artery bypass grafting (CABG) with VEST supported saphenous vein graft (SVG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 397 patients underwent CABG in a three-center setting, with or without concomitant procedures, with at least one SVG supported with an external stent. Open vein harvesting was performed in 80.3% of patients. The majority (73.3%) of patients underwent on-pump CABG, 6.8% of patients had concomitant valve surgery, and the average number of grafts per patient was three. Patients were followed for major adverse cardiac and cerebral events (MACCE) for a median duration of 24 (1-101) months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 469 of 654 SVG (71.7%) received external stents. Freedom from MACCE at 1, 3, and 5 years was 95.1% (SE 0.011), 85.4% (SE 0.021), and 82.4% (SE 0.030) respectively. Revascularization rates in territories which were grafted with a stented SV was low in general (1.28%) and statistically significantly lower than in territories grafted with a non-stented SVG (4.32%, p\u2009=\u20090.015). Arterially grafted territories confirmed low revascularization rates as well (0.9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>VEST-enhanced CABG is feasible and associated with low MACCE in real world routine practice which includes on and off pump CABG, sequential grafting, and concomitant surgery. Short- to mid-term clinical follow up suggests that VEST enhanced CABG is associated with very low target vessel revascularization rates, with most re-revascularization happening at non-grafted or non-VEST-enhanced grafted territories.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-025-03670-w","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:45:25Z","timestamp":1763981125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Venous external support enhanced coronary artery bypass grafting: a multicentric cohort experience"],"prefix":"10.1186","volume":"20","author":[{"given":"Luca Paolo","family":"Weltert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Centofanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Fusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Pljakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Lodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Sebastiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"De Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"9867","key":"3670_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","volume":"381","author":"FW Mohr","year":"2013","unstructured":"Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(13)60141-5.","journal-title":"Lancet"},{"issue":"3","key":"3670_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.semtcvs.2017.05.018","volume":"29","author":"TA Schwann","year":"2017","unstructured":"Schwann TA, Tatoulis J, Puskas J, et al. Worldwide trends in multi-arterial coronary artery bypass grafting surgery 2004\u20132014: a tale of 2 continents. Semin Thorac Cardiovasc Surg. 2017;29(3):273\u201380. https:\/\/doi.org\/10.1053\/j.semtcvs.2017.05.018.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"1","key":"3670_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0033-0620(91)90019-i","volume":"34","author":"JL Cox","year":"1991","unstructured":"Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis. 1991;34(1):45\u201368. https:\/\/doi.org\/10.1016\/0033-0620(91)90019-i.","journal-title":"Prog Cardiovasc Dis"},{"issue":"9","key":"3670_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/01.cir.97.9.916","volume":"97","author":"JG Motwani","year":"1998","unstructured":"Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97(9):916\u201331. https:\/\/doi.org\/10.1161\/01.cir.97.9.916.","journal-title":"Circulation"},{"issue":"5","key":"3670_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/SLA.0b013e318288c38d","volume":"257","author":"RE Harskamp","year":"2013","unstructured":"Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013;257(5):824\u201333. https:\/\/doi.org\/10.1097\/SLA.0b013e318288c38d.","journal-title":"Ann Surg"},{"issue":"22","key":"3670_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa1716026","volume":"378","author":"M Gaudino","year":"2018","unstructured":"Gaudino M, Benedetto U, Fremes S, et al. Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery. N Engl J Med. 2018;378(22):2069\u201377. https:\/\/doi.org\/10.1056\/NEJMoa1716026.","journal-title":"N Engl J Med"},{"issue":"4","key":"3670_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jtcvs.2015.04.061","volume":"150","author":"T Meirson","year":"2015","unstructured":"Meirson T, Orion E, Di Mario C, et al. Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia. J Thorac Cardiovasc Surg. 2015;150(4):871\u20138. https:\/\/doi.org\/10.1016\/j.jtcvs.2015.04.061.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"3670_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13019-018-0803-9","volume":"13","author":"DP Taggart","year":"2018","unstructured":"Taggart DP, Webb CM, Desouza A, et al. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial. J Cardiothorac Surg. 2018;13(1):117. https:\/\/doi.org\/10.1186\/s13019-018-0803-9.","journal-title":"J Cardiothorac Surg"},{"issue":"6","key":"3670_CR9","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.athoracsur.2015.01.060","volume":"99","author":"DP Taggart","year":"2015","unstructured":"Taggart DP, Ben Gal Y, Lees B, et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann Thorac Surg. 2015;99(6):2039\u201345. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.01.060.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"3670_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jtcvs.2021.03.120","volume":"164","author":"DP Taggart","year":"2022","unstructured":"Taggart DP, Gavrilov Y, Krasopoulos G, et al. External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: A multicenter randomized trial. J Thorac Cardiovasc Surg. 2022;164(5):1532\u2013e15412. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.03.120.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"3670_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/jamacardio.2022.1437","volume":"7","author":"DJ Goldstein","year":"2022","unstructured":"Goldstein DJ, Puskas JD, Alexander JH, et al. External support for saphenous vein grafts in coronary artery bypass surgery: a randomized clinical trial. JAMA Cardiol. 2022;7(8):808\u201316. https:\/\/doi.org\/10.1001\/jamacardio.2022.1437.","journal-title":"JAMA Cardiol"},{"key":"3670_CR12","doi-asserted-by":"publisher","unstructured":"Dushaj S, H\u00e4ussler A, Rings L, et al. External stenting for saphenous vein grafts reduces early postoperative graft failure. Interdiscip Cardiovasc Thorac Surg. 2024;38(6). https:\/\/doi.org\/10.1093\/icvts\/ivae099.","DOI":"10.1093\/icvts\/ivae099"},{"issue":"3","key":"3670_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","volume":"28","author":"GM Fitzgibbon","year":"1996","unstructured":"Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28(3):616\u201326. https:\/\/doi.org\/10.1016\/0735-1097(96)00206-9.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3670_CR14","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.jtcvs.2022.10.034","volume":"167","author":"DJ Goldstein","year":"2024","unstructured":"Goldstein DJ, Chang HL, Mack MJ, et al. Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: insights from the CTSN VEST randomized trial. J Thorac Cardiovasc Surg. 2024;167(5):1782\u2013e17925. https:\/\/doi.org\/10.1016\/j.jtcvs.2022.10.034.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"3670_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/ejcts\/ezu197","volume":"47","author":"SJ Head","year":"2015","unstructured":"Head SJ, Parasca CA, Mack MJ, et al. Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry. Eur J Cardiothorac Surg. 2015;47(4):685\u201395. https:\/\/doi.org\/10.1093\/ejcts\/ezu197.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"3670_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/JS9.0000000000000259","volume":"109","author":"S Sandner","year":"2023","unstructured":"Sandner S, Misfeld M, Caliskan E, et al. Clinical outcomes and quality of life after contemporary isolated coronary bypass grafting: a prospective cohort study. Int J Surg. 2023;109(4):707. https:\/\/doi.org\/10.1097\/JS9.0000000000000259.","journal-title":"Int J Surg"},{"issue":"22","key":"3670_CR17","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1002\/sim.8581","volume":"39","author":"H Lee","year":"2020","unstructured":"Lee H, Wong JB, Jia B, Qi X, DeLong ER. Empirical use of causal inference methods to evaluate survival differences in a real-world registry vs those found in randomized clinical trials. Stat Med. 2020;39(22):3003\u201321. https:\/\/doi.org\/10.1002\/sim.8581.","journal-title":"Stat Med"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03670-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03670-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03670-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:13:13Z","timestamp":1764180793000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03670-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03670-w","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institution\u2019s ethics committee approved data usage and analysis. The European Hospital internal reference number of the IRB is: EH-2023-002 February 17th 2023. An informed consent form was waived due to the study\u2019s retrospective nature and the minimal risk involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}